Decera Clinical Education Oncology Podcast
Episodes
Expert Highlights From the 2025 World Conference on Lung Cancer
24 Dec 2025
Contributed by Lukas
In this episode, Dr John Heymach and Dr Solange Peters discuss key data presented at the IASLC World Conference on Lung Cancer including first-line ma...
PulseCast: Highlights in Multiple Myeloma From the 2025 ASH Annual Meeting
23 Dec 2025
Contributed by Lukas
In this episode, Shaji K. Kumar, MD, reviews key highlights from ASH 2025 in multiple myeloma (MM), focusing on emerging data for bispecific antibodie...
PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting
19 Dec 2025
Contributed by Lukas
In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provide...
PulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting
18 Dec 2025
Contributed by Lukas
In this episode, Hanny Al-Samkari, MD, gives his thoughts on 5 key presentations from ASH 2025, and provides perspectives on the clinical implications...
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting
17 Dec 2025
Contributed by Lukas
In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspecti...
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
18 Nov 2025
Contributed by Lukas
In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatm...
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer
06 Nov 2025
Contributed by Lukas
In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent ...
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach
05 Nov 2025
Contributed by Lukas
In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conj...
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
31 Oct 2025
Contributed by Lukas
In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for ...
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management
28 Oct 2025
Contributed by Lukas
In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal ...
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
14 Oct 2025
Contributed by Lukas
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-ne...
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
14 Oct 2025
Contributed by Lukas
In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-ne...
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
13 Oct 2025
Contributed by Lukas
In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with HE...
Key Decisions for Selecting Bispecific Antibodies in Follicular Lymphoma
11 Sep 2025
Contributed by Lukas
In this episode, Dr Christopher Flowers and Dr John Allan discuss their experience with the use of CD20xCD3 bispecific antibodies in the treatment of ...
Pancreatic Cancer Progress: Expert Insights on Treatment Choices and Collaborating with Patients
04 Sep 2025
Contributed by Lukas
Listen in as Zev A. Wainberg, MD; Paul E. Oberstein, MD; and Mark O’Hara, MD, discuss the evolving treatment landscape for metastatic pancreatic can...
Latest Advances in CAR T-Cell Therapy for Lymphomas and Multiple Myeloma
03 Sep 2025
Contributed by Lukas
In this episode, Dr Brad Kahl and Dr Noopur Raje discuss the recent advances and emerging data for CAR T-cell therapy in lymphomas and multiple myelom...
CDK4/6 Inhibitors in HR-Positive/HER2-Negative Breast Cancer: Experts Answer Your Questions
26 Aug 2025
Contributed by Lukas
In this episode, Drs William J. Gradishar, Heather McArthur, and Joanne Mortimer address audience questions from a recent live event on the use of CDK...
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
15 Aug 2025
Contributed by Lukas
In this episode, Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the emerging role of DLL3-targeted agents in the management of extrapulmon...
Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
12 Aug 2025
Contributed by Lukas
In this episode, listen to Kelly Romo, PharmD, BCOP; and Shauna Kraft, PharmD, BCOP, share their takeaways from a live webinar on available emerging s...
Key Advances in Lymphomas and Acute Lymphocytic Leukemia From EHA and ICML 2025
28 Jul 2025
Contributed by Lukas
In this podcast, Max S. Topp, MD, and Pier Luigi Zinzani, MD, PhD, explore the current and future implications of some of their top choices of studies...
Experts Discuss Key Studies in Breast Cancer: Independent Conference Coverage of the 2025 ASCO Annual Meeting
25 Jul 2025
Contributed by Lukas
In this episode, Kevin Kalinsky, MD, MS, FASCO, and Sara M. Tolaney, MD, MPH, discuss the most clinically relevant data in breast cancer presented at ...
Takeaways From a Large Educational Program on Available and Emerging Treatment Options for HER2-Positive mBC
25 Jul 2025
Contributed by Lukas
In this episode, listen to Laura M. Spring, MD; and Shipra Gandhi, MD, MS, share their takeaways from a large educational program on available and eme...
A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
24 Jul 2025
Contributed by Lukas
In this episode, Eunice Wang, MD and Eytan Stein, MD explore the latest key clinical updates on menin inhibitors in AML. This episode unpacks evolving...
BTK Inhibitors in CLL: Key Clinical Updates From ASCO & EHA 2025
23 Jul 2025
Contributed by Lukas
In this episode, James Davis, PharmD, BCOP and Victoria Nachar, PharmD, BCOP summarize the latest key clinical updates on BTK inhibitors in CLL based ...
Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma
18 Jul 2025
Contributed by Lukas
In this episode, Joseph W. Franses, MD, PhD; Neehar Parikh, MD, MS; and Mark Yarchoan, MD, share their thoughts on incorporating immune checkpoint in...
Personalized Pathways: Redefining Frontline Hodgkin Lymphoma Treatment Strategies
18 Jul 2025
Contributed by Lukas
In this episode, Jonathan W. Friedberg, MD; Alex F. Herrera, MD; and Kara Kelly, MD, discuss the latest frontline treatment options for advanced Hodgk...
Experts Discuss CELMoDs in Myeloma
15 Jul 2025
Contributed by Lukas
In this episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Sagar Lonial, MD, FACP, discuss key topics with CELMoD therapy for multiple myeloma...
Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities
29 May 2025
Contributed by Lukas
In this podcast episode, Sara A. Hurvitz, MD, FACP, La-Urshalar B. Brock, FNP-BC, CNM, and Jordan Hill, PharmD, BCOP, discuss the important role of th...
Uncovering Safety and Signposts to the Future: AEs With HER2-Targeted ADCs and Future Applications
16 May 2025
Contributed by Lukas
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, discuss the evolving safety c...
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies
05 May 2025
Contributed by Lukas
In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2...
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer
24 Apr 2025
Contributed by Lukas
In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small...
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies
21 Apr 2025
Contributed by Lukas
In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alter...
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC
25 Mar 2025
Contributed by Lukas
In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the cur...
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
20 Feb 2025
Contributed by Lukas
In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questio...
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
10 Feb 2025
Contributed by Lukas
In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recent...
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer
09 Jan 2025
Contributed by Lukas
In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways ...
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
22 Oct 2024
Contributed by Lukas
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:3 bispecific a...
Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations
16 Oct 2024
Contributed by Lukas
In this episode, Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss important topics related to gastroenteropancreatic neuroendocrine tumor...
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
01 Oct 2024
Contributed by Lukas
In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data p...
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
30 Sep 2024
Contributed by Lukas
In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choic...
Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC
06 Sep 2024
Contributed by Lukas
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available and emerging clinical data for secon...
Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC
05 Sep 2024
Contributed by Lukas
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the available clinical data in support of frontlin...
ROS1-Alterations and Molecular Testing in Advanced NSCLC
28 Aug 2024
Contributed by Lukas
In this episode, listen to Alice T. Shaw, MD, PhD, and Jessica J. Lin, MD, share their thoughts on the current understanding of ROS1 rearrangements i...
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
05 Aug 2024
Contributed by Lukas
In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presente...
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs
22 Jul 2024
Contributed by Lukas
In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest da...
Current Clinical Practice and NCCN Guidelines for CLL/SLL
18 Jul 2024
Contributed by Lukas
In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align curr...
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs
12 Jul 2024
Contributed by Lukas
In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented ...
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways
11 Jul 2024
Contributed by Lukas
In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including:Rationale for ta...
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer
09 Jul 2024
Contributed by Lukas
In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest da...
Congress to Clinic: Expert Takeaways on Emerging Data for AML
08 Jul 2024
Contributed by Lukas
In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presen...
Congress to Clinic: Expert Takeaways on Emerging Data for MDS
05 Jul 2024
Contributed by Lukas
In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic ...
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer
14 May 2024
Contributed by Lukas
In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the la...
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
07 May 2024
Contributed by Lukas
In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share str...
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
28 Mar 2024
Contributed by Lukas
In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to...
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
18 Mar 2024
Contributed by Lukas
In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for pat...
Current Considerations for Adverse Event Management With HER3-Directed Agents
26 Dec 2023
Contributed by Lukas
The third and final episode in a 3-part series covers the safety profile of and considerations for managing adverse events associated with HER3-target...
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
26 Dec 2023
Contributed by Lukas
This second episode in a 3-part series on HER3-targeted agents in NSCLC covers current clinical trials with HER3-targeted therapy, including:Recent da...
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
26 Dec 2023
Contributed by Lukas
This first episode in a 3-part series tackles the role of HER3 in cancer, specifically in NSCLC, and how HER3 can be effectively targeted with ADCs.Pr...
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
04 Dec 2023
Contributed by Lukas
In this episode, Brian Slomovitz, MD, MS, FACOG, and Keiichi Fujiwara, MD, PhD, share their thoughts and opinions on seminal data presented at the 202...
Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
30 Nov 2023
Contributed by Lukas
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosi...
A Year in Review and a Look to the Future: BTKi in CLL and MCL
20 Nov 2023
Contributed by Lukas
In this episode, Ana Marin-Niebla, MD, PhD, and Stephan Stilgenbauer, MD, discuss key trial data on the use of BTK inhibitors in CLL and MCL throughou...
Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
17 Nov 2023
Contributed by Lukas
In this episode, Isabelle Ray-Coquard, MD, PhD, and Ana Oaknin, MD, PhD, provide expert insights on new clinical trial data presented at the 2023 ESMO...
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
07 Nov 2023
Contributed by Lukas
In this episode, Aakash Desai, MD; Narjust Florez, MD; and Paolo Tarantino, MD, discuss the biologic rationale and clinical development of agents targ...
Improving Care for Black Patients With Endometrial Cancer
06 Nov 2023
Contributed by Lukas
In this episode, Dr Leslie Boyd and Adrienne Moore, a patient advocate and endometrial cancer survivor, discuss how healthcare professionals can partn...
Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
13 Oct 2023
Contributed by Lukas
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide expert insights on key updates and new clinical trial data presented...
New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023
04 Oct 2023
Contributed by Lukas
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at SOHO 2023 evaluating the use of BTK inhibitors...
New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023
17 Aug 2023
Contributed by Lukas
In this episode, Catherine C. Coombs, MD, and Toby Eyre, MBChB, MD, discuss key trials presented at ICML 2023 evaluating the use of BTK inhibitors in ...
New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
28 Jul 2023
Contributed by Lukas
In this episode, Catherine C. Coombs, MD, MS, and Toby Eyre, MBChB, MD, discuss key trials presented at EHA 2023 evaluating the use of BTK inhibitors ...
Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
22 Jun 2023
Contributed by Lukas
In this episode, Kathleen Moore, MD, MS, and Nicoletta Colombo, MD, PhD, provide expert insights on key updates and new clinical trial data presented ...
Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
04 May 2023
Contributed by Lukas
In this episode, David Scott Miller, MD, FACOG, FACS, and Linda Duska, MD, MPH, provide expert insights on practice-changing data and other new findin...
Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma
26 Apr 2023
Contributed by Lukas
In this episode, Suzanne Lentzsch, MD, Ph.D., and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of BCMA-targeted therapies in the management ...
Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts
11 Apr 2023
Contributed by Lukas
In this episode, John Mascarenhas, MD, and Ruben A. Mesa, MD, FACP, discuss current best practices and emerging approaches for treating patients wi...
BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges
05 Apr 2023
Contributed by Lukas
In this episode, Banu Arun, MD; Allison Butts, PharmD, BCOP; and Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP, discuss the role of BRCA testing and a...
Experts Discuss Claudin 18.2: A New Target for Precision Care of Gastric and Gastroesophageal Cancers
28 Mar 2023
Contributed by Lukas
In this podcast episode, Samuel Klempner, MD, and Gregory Botta, MD, PhD, provide expert commentary on the rationale and development of novel agents u...
Treatment Considerations for Patients With Essential Thrombocythemia: A Conversation Between Experts
23 Feb 2023
Contributed by Lukas
In this podcast episode, Prithviraj Bose, MD, and Andrew Kuykendall, MD, discuss their contemporary approaches to the treatment of patients with esse...
FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia
20 Feb 2023
Contributed by Lukas
In this episode, Daniel J. DeAngelo, MD, PhD; Kjeld Schmiegelow, MD, DMSci; and Emily Curran, MD, answer key questions asked by the audience during a ...
Experts Answer Questions on the Management of Patients With T-Cell Lymphomas
17 Feb 2023
Contributed by Lukas
In this podcast episode, Steven M. Horwitz, MD; Pamela B. Allen, MD, MSc; and Kerry Savage, MD, MSc, answer questions from an audience of healthcare p...
Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes
17 Feb 2023
Contributed by Lukas
In this podcast, Rami Komrokji, MD; María Díez Campelo, MD, PhD; and Amer Zeidan, MBBS, MHS answer questions from an audience of healthcare professi...
Individualizing Care for Patients With Triple-Negative Breast Cancer
18 Jan 2023
Contributed by Lukas
In this podcast episode from a live CCO Cancer Conversations webinar, Mark Pegram, MD, and Sara Tolaney, MD, MPH, provide expert perspectives on optim...
Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts
11 Jan 2023
Contributed by Lukas
In this podcast episode, Raajit Rampal, MD, PhD, and Brady L. Stein, MD, MHS, discuss their contemporary approaches to the treatment of patients with ...
HCC Surveillance: Challenges and Opportunities
03 Jan 2023
Contributed by Lukas
In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveill...
A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
13 Dec 2022
Contributed by Lukas
In this episode, Zoe Lanham, a woman with high-risk hormone receptor–positive/HER2-negative early breast cancer, discusses the importance of effecti...
Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers
29 Nov 2022
Contributed by Lukas
In this episode, Prof Isabelle Ray Coquard, MD, PhD, and Ignace Vergote, MD, PhD, share their thoughts on key studies of interested presented at the 2...
The Transgender Cancer Experience: A Conversation Between an Oncologist and a Transmasculine Individual on Navigating the Healthcare System
29 Nov 2022
Contributed by Lukas
In this episode, activist and breast cancer survivor Yee Won Chong shares his experience as a transmasculine person navigating the healthcare system w...
Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions
09 Nov 2022
Contributed by Lukas
In this episode, Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on topics related to the...
New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting
28 Oct 2022
Contributed by Lukas
In this episode, Christopher R. Flowers, MD, MS, and Kami Maddocks, MD, discuss their choices of recent important trials presented at the Society of H...
Expert Thoughts on Key Trials of Interest for Ovarian and Cervical Cancer at the IGCS 2022 Annual Global Meeting
24 Oct 2022
Contributed by Lukas
In this episode,Susana Banerjee, MBBS, MA, PhD, and Mansoor Raza Mirza, MD, share their thoughts on key studies of interested presented at the IGCS 2...
Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape
24 Oct 2022
Contributed by Lukas
In this podcast episode from Clinical Care Options, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD, answer questions from a liv...
Expert Insights on Key Updates From the 2022 ESMO Congress on PARP Inhibitors in Ovarian Cancer
04 Oct 2022
Contributed by Lukas
In this episode, Domenica Lorusso, MD, PhD, and Alexandra Leary, MD, PhD, provide their expert insights on key updates presented for ovarian cancer tr...
Managing EGFR-Mutated Non-Small-Cell Lung Cancer in Today’s Clinic: Expert Answers to Frequently Asked Questions
28 Sep 2022
Contributed by Lukas
In this episode, Ryan D. Gentzler, MD, MS, and Jonathan Riess, MD, MS, answer audience questions on managing EGFR-mutated non-small-cell lung cancer (...
New Evidence With BTK Inhibitor Therapy in CLL and MCL From the Pan Pacific Lymphoma Conference 2022
30 Aug 2022
Contributed by Lukas
In this episode, Julie M. Vose, MD, MBA, and Matthew S. Davids, MD, MMSc, discuss their choices of recent important trials presented at the Pan Pacifi...
Experts Discuss Challenges in Advanced Hepatocellular Carcinoma Management
22 Aug 2022
Contributed by Lukas
In this podcast episode from Clinical Care Options (CCO), Heinz-Josef Klumpen, MD, PhD, and Chris Verslype, MD, PhD, discuss challenges in selecting...
HER2-Positive Breast Cancer: Current Approaches for Quality Care
28 Jul 2022
Contributed by Lukas
In this episode, Erika P. Hamilton, MD, and Komal Jhaveri, MD, discuss their approaches to and key studies for current management of patients with HER...
New Evidence With BTK Inhibitor Therapy in CLL and MCL From EHA 2022
21 Jul 2022
Contributed by Lukas
In this episode, Othman Al-Sawaf, MD, and Lydia Scarfò, MD, discuss key trials presented at EHA 2022 evaluating the use of BTK inhibitors in chronic ...
New Evidence With BTK Inhibitor Therapy in CLL and MCL From ASCO 2022
06 Jul 2022
Contributed by Lukas
In this episode, Brad S. Kahl, MD, and Anthony Mato, MD, MSCE, discuss their choices of 3 recent important trials presented at ASCO 2022 evaluating th...
Expert Insights on New Data From ASCO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
30 Jun 2022
Contributed by Lukas
In this episode, Jubilee Brown, MD, and Elisabeth Diver, MD, provide expert insights on new data presented at ASCO 2022 for ovarian, endometrial, and ...
Expert Insight on Key Data From SGO 2022 Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
19 May 2022
Contributed by Lukas
In this episode, David Scott Miller, MD, FACOG, FACS, and Angeles Alvarez Secord, MD, MHSc, provide expert insights on key data presented at SGO 2022 ...
Call to Action and Reflection: Inclusive, Compassionate, and High-Quality Healthcare for Transgender Individuals
13 May 2022
Contributed by Lukas
In this episode for all healthcare professionals and any patient-facing clinical staff, Nelson F. Sanchez, MD, shares key insights on the need for equ...
Inclusive Healthcare for Transgender Individuals: Insights From a Healthcare Professional’s Transition Experience
02 May 2022
Contributed by Lukas
In this episode, Pharmacist Olivia Buckoski shares her experience undergoing medical and social transition and offers advice from the perspective of b...
Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials
15 Apr 2022
Contributed by Lukas
In this episode, Jyoti D. Patel, MD, and Ani Balmanoukian, MD, discuss several studies investigating agents targeting TIGIT, an emerging immune checkp...